Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations ...

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain.

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

The number of employees laid off and companies letting people go increased year over year during the first half of 2025.

Fintel reports that on July 8, 2025, Scotiabank downgraded their outlook for Sage Therapeutics (NasdaqGM:SAGE) from Sector ...

DEMOCRATIC U.S. SENATE CANDIDATE NATHAN SAGE OF IOWA SAYS HE HAS RAISED OVER $705,000 IN THE SECOND QUARTER OF 2025. SAGE IS ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...

Sage Therapeutics, Inc. (NASDAQ: SAGE) related to its sale to Supernus Pharmaceuticals, Inc. Upon completion of the proposed ...

Astellas Pharma Inc. recently created a new role — that of chief research & development officer — and named Cambridge ...

After the FDA rejection of Zurzuvae in one type of depression and the triple failure of neuro asset dalzanemdor, Sage was ...

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...